LSV Asset Management Has $250.82 Million Stock Position in Cardinal Health, Inc. (NYSE:CAH)

→ get a piece of the profit from this land (From True Market Insiders) (Ad)

LSV Asset Management cut its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 0.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,488,290 shares of the company's stock after selling 21,602 shares during the period. LSV Asset Management owned approximately 1.02% of Cardinal Health worth $250,820,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Aaron Wealth Advisors LLC boosted its holdings in shares of Cardinal Health by 1.2% in the 4th quarter. Aaron Wealth Advisors LLC now owns 8,369 shares of the company's stock valued at $844,000 after purchasing an additional 97 shares during the last quarter. Schechter Investment Advisors LLC boosted its holdings in shares of Cardinal Health by 4.1% in the 4th quarter. Schechter Investment Advisors LLC now owns 2,480 shares of the company's stock valued at $250,000 after purchasing an additional 98 shares during the last quarter. Cypress Capital Group boosted its holdings in shares of Cardinal Health by 0.7% in the 3rd quarter. Cypress Capital Group now owns 17,133 shares of the company's stock valued at $1,487,000 after purchasing an additional 111 shares during the last quarter. Hexagon Capital Partners LLC boosted its holdings in shares of Cardinal Health by 53.6% in the 4th quarter. Hexagon Capital Partners LLC now owns 338 shares of the company's stock valued at $34,000 after purchasing an additional 118 shares during the last quarter. Finally, Monument Capital Management raised its stake in shares of Cardinal Health by 3.0% in the 3rd quarter. Monument Capital Management now owns 4,639 shares of the company's stock valued at $403,000 after acquiring an additional 136 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.


Wall Street Analyst Weigh In

A number of equities analysts have recently commented on CAH shares. Robert W. Baird cut their target price on shares of Cardinal Health from $134.00 to $128.00 and set an "outperform" rating on the stock in a research note on Friday. UBS Group raised their target price on shares of Cardinal Health from $122.00 to $125.00 and gave the company a "buy" rating in a research note on Monday, February 5th. StockNews.com raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Thursday. Argus raised shares of Cardinal Health from a "hold" rating to a "buy" rating in a research note on Friday, February 9th. Finally, SVB Leerink initiated coverage on shares of Cardinal Health in a research note on Monday, February 26th. They set an "outperform" rating and a $125.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $105.79.

View Our Latest Research Report on CAH

Cardinal Health Stock Down 4.0 %

Shares of CAH traded down $4.07 during midday trading on Friday, hitting $98.91. The company had a trading volume of 3,446,183 shares, compared to its average volume of 2,028,678. The company's 50 day moving average price is $109.10 and its 200 day moving average price is $105.09. The stock has a market cap of $24.06 billion, a price-to-earnings ratio of 43.96, a PEG ratio of 0.99 and a beta of 0.71. Cardinal Health, Inc. has a 52 week low of $77.56 and a 52 week high of $116.04.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, May 2nd. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $1.95 by $0.13. The company had revenue of $54.90 billion during the quarter, compared to the consensus estimate of $56.05 billion. Cardinal Health had a net margin of 0.25% and a negative return on equity of 54.74%. The company's revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.74 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 7.34 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a $0.5006 dividend. The ex-dividend date was Thursday, March 28th. This represents a $2.00 dividend on an annualized basis and a yield of 2.02%. Cardinal Health's payout ratio is currently 88.89%.

Cardinal Health Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Stories

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

→ get a piece of the profit from this land (From True Market Insiders) (Ad)

Should you invest $1,000 in Cardinal Health right now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Featured Articles and Offers

5 Hottest CEO Stock Purchases

5 Hottest CEO Stock Purchases

No insider is more significant than the CEO. This is a list of the five most significant CEO purchases in Q1 2024 based on dollar volume.

Search Headlines: